Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical utility of genomic sequencing for hereditary cancer syndromes: An observational cohort study
    Journal Article

    Shickh, S.; Mighton, C.; Clausen, M.; Sam, J.; Hirjikaka, D.; Reble, E.; Graham, T.; Panchal, S.; Eisen, A.; Elser, C.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Electronic symptom monitoring during metastatic cancer treatment: Does it work better for some patients than for others (AFT-39)?
    Meeting Abstract

    Deal, A.; Ginos, B.; Schrag, D.; Jansen, J.; Henson, S.; Stover, A.; Carr, P.; Spears, P.; Jonsson, M.; Bennett, A.; more...
    Quality of Life Research (2024)

    Fulltext@MSK | Save
  • Association between alert notification intensity during early study participation and time to study discontinuation in the AFT-39 PRO-TECT cluster-randomized clinical trial
    Meeting Abstract

    Ginos, B.; Dueck, A. C.; Schrag, D.; Jansen, J.; Henson, S.; Stover, A. M.; Carr, P.; Spears, P. A.; Jonsson, M.; Deal, A. M.; more...
    Quality of Life Research (2024)

    Fulltext@MSK | Save
  • Inavolisib or placebo in combination with palbociclib and fulvestrant in patients with PIK3CA-mutated, hormone receptor-positive, HER2-negative locally advanced or metastatic breast cancer: Phase III INAVO120 primary analysis
    Meeting Abstract

    Kümmel, S.; Jhaveri, K.; Im, S. A.; Saura, C.; Juric, D.; Loibl, S.; Kalinsky, K.; Schmid, P.; Loi, S.; Thanopoulou, E.; more...
    Oncology Research and Treatment (2024)

    Fulltext@MSK | Save
  • Proton craniospinal irradiation for patients with solid tumor leptomeningeal metastasis- Final analysis of a phase II study
    Meeting Abstract

    Yang, J. T.; Yerramilli, D.; Pentsova, E.; Wolden, S. L.; Young, R. J.; Correa, D.; Zhang, Z.; Zheng, J.; Baser, R. E.; Betof Warner, A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Tumor adaptation to PI3K inhibition and its stability increases as a function of time and is overcome by combined inhibiting Bcl2 family proteins
    Meeting Abstract

    Mukherjee, R.; Vanaja, K. G.; Sharma, M.; Solomon, H.; De Stanchina, E.; Chandarlapaty, S.; Rosen, N.
    European Journal of Cancer (2024)

    Fulltext@MSK | Save
  • Identification of biomarkers of response and the mechanism of action of a selective androgen receptor modulator in estrogen receptorpositive breast cancer patient-derived xenografts
    Meeting Abstract

    Monserrat, L.; García García, J.; Gutiérrez, C. M.; Viaplana, C.; Brasó-Maristany, F.; Bellet, M.; Chandarlapaty, S.; Nonell, L.; Ponomarenko, J.; Canals, F.; more...
    European Journal of Cancer (2024)

    Fulltext@MSK | Save
  • Final OS analysis from the phase 3 TROPiCS-02 study: sacituzumab govitecan in HR+/HER2 - metastatic breast cancer
    Meeting Abstract

    Rugo, H. S.; Bardia, A.; Marme, F.; Cortes, J.; Schmid, P.; Loirat, D.; Tredan, O.; Ciruelos, E.; Dalenc, F.; Pardo, P. G.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Assessing 2024 oncology advances and looking ahead
    Editorial

    Iyengar, N. M.
    Oncology (Norwalk) (2024)

    Fulltext@MSK | Save
  • Imlunestrant, an oral selective estrogen receptor degrader, as monotherapy and in combination with targeted therapy in estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: Phase Ia/Ib EMBER study
    Journal Article

    Jhaveri, K. L.; Lim, E.; Jeselsohn, R.; Ma, C. X.; Hamilton, E. P.; Osborne, C.; Bhave, M.; Kaufman, P. A.; Beck, J. T.; Sanchez, L. M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save